Follow the サンバイオ株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, サンバイオ株式会社 has published 19 public disclosures. Market capitalisation: €79.7bn. The latest transaction was filed on 22 July 2026 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. The full history is free.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
SanBio Company is a company focused on the health and pharmaceutical sector, dedicated to developing innovative therapies. It is listed on the XTKS market.